Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Dinutuximab by United Therapeutics for Osteosarcoma: Likelihood of Approval
Dinutuximab is under clinical development by United Therapeutics and currently in Phase II for Osteosarcoma. According to GlobalData, Phase II...